TP53 and T-cell non-Hodgkin lymphoma: Moreover, reducing the levels of p53 in SAC-deficient mice showed increased T cell lymphoma and decreased survival [125–128], suggesting that p53 could limit the tumorigenesis potential of CIN in vivo by restraining the viability of aneuploid cells (summarized in Table 1).